The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders
Wai Chin Chong(Hudson Institute of Medical Research), Philip M. Hansbro(University of Technology Sydney), Kate Schroder(The University of Queensland), Kamal Dua(University of Technology Sydney), Madhur D. Shastri(University of Tasmania), Shakti D. Shukla(University of Technology Sydney), Alan Hsu(Harvard University Press), Nicole G. Hansbro(University of Technology Sydney), Rahul P. Patel(University of North Carolina at Chapel Hill), Prabuddha S. Pathinayake(Hunter Medical Research Institute), Matt D. Johansen(University of Technology Sydney), Gregory M. Peterson(University of Tasmania), Peter Wark(John Hunter Hospital)
Cited by 50
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
|The Journal of Experimental Medicine|2005|1.2k
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
|Nature Chemical Biology|2019|975
Noncanonical inflammasome signaling elicits gasdermin D–dependent neutrophil extracellular traps
|Science Immunology|2018|608
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507